T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTOR
801
DELISTED
MERITOR, Inc.
MTOR
| $94M | 0.01% |
4,014,506
-663,164
| -14% | -$17.4M |
|
802
Orion
OEC
$360M
| $93.6M | 0.01% |
4,928,673
+731,827
| +17% | +$14.5M |
|
803
Tetra Tech
TTEK
$9.33B
| $93.6M | 0.01% |
3,833,450
-82,935
| -2% | -$2.09M |
|
|
UNVR
804
DELISTED
Univar Solutions Inc.
UNVR
| $93.5M | 0.01% |
3,833,458
-143,460
| -4% | -$3.59M |
|
805
Certara
CERT
$1.24B
| $93M | 0.01% |
3,282,955
+259,100
| +9% | +$7.19M |
|
806
Ford
F
$55.4B
| $92.4M | 0.01% |
6,221,112
-10,243
| -0.2% | -$136K |
|
|
SGI
807
Somnigroup International
SGI
$14B
| $92.2M | 0.01% |
2,353,324
-5,339
| -0.2% | -$205K |
|
808
Allogene Therapeutics
ALLO
$683M
| $92.2M | 0.01% |
3,535,184
+78,431
| +2% | +$2.24M |
|
|
CHUY
809
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $92.1M | 0.01% |
2,472,562
-666,807
| -21% | -$28.4M |
|
810
Advantage Solutions
ADV
$423M
| $92M | 0.01% |
341,049
+5,482
| +2% | +$1.69M |
|
811
Texas Roadhouse
TXRH
$13.6B
| $91.6M | 0.01% |
951,670
-333,497
| -26% | -$32.8M |
|
812
Newmont
NEM
$120B
| $91.5M | 0.01% |
1,444,004
-1,784,902
| -55% | -$120M |
|
|
ATRI
813
DELISTED
Atrion Corp
ATRI
| $91.3M | 0.01% |
146,983
+8,405
| +6% | +$5.25M |
|
814
Takeda Pharmaceutical
TAK
$55.5B
| $90.7M | 0.01% |
5,386,303
-50,595
| -0.9% | -$861K |
|
815
Royalty Pharma
RPRX
$26.1B
| $90.2M | 0.01% |
2,199,853
-154,365
| -7% | -$6.57M |
|
|
AVNS
816
DELISTED
Avanos Medical
AVNS
| $90M | 0.01% |
2,475,276
-745,607
| -23% | -$30.8M |
|
817
Red Robin
RRGB
$183M
| $90M | 0.01% |
2,718,720
-118,417
| -4% | -$4.04M |
|
818
LegalZoom.com
LZ
$993M
| $90M | 0.01% |
+2,377,758
| New | +$90M |
|
819
Palo Alto Networks
PANW
$323B
| $90M | 0.01% |
1,454,658
+278,022
| +24% | +$16.5M |
|
820
Alcoa
AA
$13.1B
| $90M | 0.01% |
2,441,837
-4,231,174
| -63% | -$154M |
|
821
ResMed
RMD
$32.9B
| $89.9M | 0.01% |
364,549
+130,615
| +56% | +$27.5M |
|
822
Globant
GLOB
$1.77B
| $89.7M | 0.01% |
409,356
+354,579
| +647% | +$77.9M |
|
823
Boston Omaha
BOC
$431M
| $89.6M | 0.01% |
2,825,229
+733,630
| +35% | +$21.3M |
|
824
Performance Food Group
PFGC
$16.4B
| $89.6M | 0.01% |
1,847,330
-50,538
| -3% | -$2.67M |
|
825
Digital Realty Trust
DLR
$73.1B
| $89.5M | 0.01% |
594,785
-158,808
| -21% | -$24M |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.